LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer

• Autores principales: Ying Zeng (Autor), Guo Wang (Autor), Cheng-Fang Zhou (Autor), Hai-Bo Zhang (Autor), Hong Sun (Autor), Wei Zhang (Autor), Hong-Hao Zhou (Autor), Rong Liu (Autor), Yuan-Shan Zhu (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2019-05-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

BackgroundThe purpose of this study is to develop an effective but concise long non-coding RNA (lncRNA) expression signature that can predict response to neoadjuvant chemotherapy for breast cancer (BC) patients.MethodslncRNA expression profiling in 1102 BC patients from Gene Expression Omnibus datas...